FDA Aims To Bolster Oversight Of Drug Safety Data
The U.S. Food and Drug Administration is set to hold a public workshop to examine methods of collecting and reporting data about drugs' side effects in a bid to address widespread...To view the full article, register now.
Already a subscriber? Click here to view full article